Pharma Company Gains Precise Gene Edits in $2B Biotech Deal
A global drug maker is acquiring access to a #biotechnology company's precise #genome editing techniques to develop new #therapies for rare and cardiometabolic disorders.
https://sciencebusiness.technewslit.com/?p=44824
#News #Science #Business #Genomics #GeneEditing #Crispr #Enzymes #Chemistry #BasePairs #BaseEditing #Collaboration #Licensing #RareDiseases
#biotechnology #genome #therapies #News #science #business #genomics #geneediting #crispr #enzymes #chemistry #basepairs #baseediting #collaboration #licensing #rarediseases